Anticancer Res

1. TERATANI Y, Sadanaga T, Wang S, Kusukawa J, et al
   Nuclear Localization of Chitinase 3-like 1 Is a Novel Biomarker for Detecting the Early Stage of Inflammation-associated Dysplasia in the Oral Cavity.
   Anticancer Res. 2025;45:3469-3478.
   

   >> Share

   
   
2. FUJIYOSHI K, Sugihara R, Miyamoto N, Watanabe Y, et al
   Comparison of Comprehensive Genomic Profiling Testing "Ion Torrent Genexus Sequencer" With FoundationOne.
   Anticancer Res. 2025;45:3479-3486.
   

   >> Share

   
   
3. TAKIMOTO R, Kamigaki T, Okada S, Ibe H, et al
   Clinical Evaluation of Immune Cell Therapy in Esophageal Cancer Resistant to Immunochemotherapy.
   Anticancer Res. 2025;45:3553-3559.
   

   >> Share

   
   
4. KIMURA S, Aoki M, Nishi K, Takeuchi T, et al
   CD155 Expression Predicts Poor Prognosis in OTSCC and Correlates With TIGIT Expression and Tumor Budding.
   Anticancer Res. 2025;45:3511-3522.
   

   >> Share

   
   
5. AOYAMA T, Maezawa Y, Hashimoto I, Kazama K, et al
   The C-reactive Protein to Albumin Ratio (CAR) Is an Independent Prognostic Factor for Recurrence in Patients With Esophageal Cancer After Esophagectomy.
   Anticancer Res. 2025;45:3365-3372.
   

   >> Share

   
   
6. FUJIWARA K, Mukohyama J, Kato F, Kato A, et al
   Late-onset Colonic Graft and Overlying Skin Necrosis 15 Years After Esophagectomy and Gastrectomy: A Case Report.
   Anticancer Res. 2025;45:3561-3566.
   

   >> Share

   
   

   
   BMC Cancer

7. EMERICK C, Silva LC, Jang Y, Vargas PA, et al
   Assessing the selective impact of histone modifying drugs on adenoid cystic carcinoma cells and their stem cell counterparts.
   BMC Cancer. 2025;25:1277.
   

   >> Share

   
   
8. DONA MG, Paolini F, Benevolo M, Rollo F, et al
   Detection and significance of HPV16 E5-specific productive transcripts in oropharyngeal carcinoma.
   BMC Cancer. 2025;25:1274.
   

   >> Share

   
   
9. MCLAUGHLIN RA, McMahon D, Cluxton C, Fitzpatrick OM, et al
   Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicity.
   BMC Cancer. 2025;25:1280.
   

   >> Share

   
   
10. LIU J, Duan Y, Wang Y, Li X, et al
    Novel prediction nomogram model for recurrent/persistent disease versus the American thyroid association recurrence risk stratification in patients with N1b papillary thyroid cancer: a retrospective cohort study.
    BMC Cancer. 2025;25:1271.
    

    >> Share

    
    
11. GUO LF, Yu YF, Lu ZZ, Lin Q, et al
    Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
    BMC Cancer. 2025;25:1268.
    

    >> Share

    
    
12. CHEN J, Miao C, Wang X, Yang L, et al
    Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study.
    BMC Cancer. 2025;25:1270.
    

    >> Share

    
    
13. LIU Q, Hu J, Liu L, He W, et al
    Development of a nomogram based on body composition and tumor burden indicators to predict lymph node metastasis in patients with T1 esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1266.
    

    >> Share

    
    
14. ZHONG W, Liu J, Xie J, Zhang Z, et al
    Integrative analysis of saliva-derived exosomal proteome and lipidome for the diagnosis of esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1254.
    

    >> Share

    
    
15. ZHANG Q, Huang W, Chen X, Yan Z, et al
    Watch-and-wait strategy in patients with objective response after immuno-chemotherapy for locally recurrent nasopharyngeal carcinoma: a pilot study.
    BMC Cancer. 2025;25:1255.
    

    >> Share

    
    

    
    Br J Oral Maxillofac Surg

16. COGHLAN K, Sheill G, O Connell JE, Bowe C, et al
    Physical function of head and neck cancer survivors in the first year after treatment: an exploratory descriptive investigation.
    Br J Oral Maxillofac Surg. 2025 Jun 28:S0266-4356(25)00148.
    

    >> Share

    
    

    
    Head Neck

17. KALAVACHERLA S, Bendik J, Victor M, Carter H, et al
    Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas.
    Head Neck. 2025 Aug 4. doi: 10.1002/hed.70007.
    

    >> Share

    
    
18. LI B, Cheng G, Mo Y, Dai J, et al
    Diagnostic Performance of Imaging-Based Artificial Intelligence Models for Preoperative Detection of Cervical Lymph Node Metastasis in Clinically Node-Negative Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
    Head Neck. 2025 Aug 4. doi: 10.1002/hed.70000.
    

    >> Share

    
    
19. BROOKS PJ, Bratman SV
    Liquid Biopsies in Head and Neck Cancers: Recent Developments Across Biofluids, Analytes, and Molecular Features.
    Head Neck. 2025 Aug 7. doi: 10.1002/hed.70009.
    

    >> Share

    
    

    
    Histopathology

20. ANGERILLI V, Galuppini F, Brignola S, Businello G, et al
    Predictors of neoplastic progression in gastroesophageal lesions indefinite for dysplasia.
    Histopathology. 2025;87:424-435.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

21. LANGER CJ, Harris J, Horwitz EM, Kies M, et al
    Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination with Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): Long-term follow-up of NRG Oncology Radiation Therapy Oncolog
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06032.
    

    >> Share

    
    

    
    J Clin Oncol

22. BURTNESS B, Flamand Y, Quon H, Weinstein GS, et al
    Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer.
    J Clin Oncol. 2025;43:2559-2565.
    

    >> Share

    
    

    
    J Nucl Med

23. VON HINTEN J, Viering O, Bundschuh RA, Cagliyan F, et al
    Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine-Refractory Metastatic Thyroid Cancer.
    J Nucl Med. 2025 Jun 5:jnumed.125.270055. doi: 10.2967/jnumed.125.270055.
    

    >> Share

    
    

    
    Laryngoscope

24. GALLAGHER TJ, Kokot NC
    In Response to Reduced Mortality With Treatment of Anxiety and Depression Among Head and Neck Cancer Survivors.
    Laryngoscope. 2025 Aug 2. doi: 10.1002/lary.32467.
    

    >> Share

    
    
25. ZALAQUETT NG, Hosri J, Elwell Z, Semaan Z, et al
    Factors Influencing the Delay in Head and Neck Cancer Diagnosis in Lebanon.
    Laryngoscope. 2025 Aug 4. doi: 10.1002/lary.32470.
    

    >> Share

    
    

    
    Oral Oncol

26. HUMBERT M, Perreard M, Licaj I, Bouhnik AD, et al
    Social health at 5 years after diagnosis of head and neck cancer.
    Oral Oncol. 2025;168:107567.
    

    >> Share

    
    
27. JENNIFER LG, Larnaudie A, Bene MC, Cocherie T, et al
    Relationships between oral microbiome and head and neck squamous cell carcinoma: a systematic review.
    Oral Oncol. 2025;168:107571.
    

    >> Share

    
    
28. MATSUDA Y, Fujioka-Kobayashi M, Tatsumi H, Osako-Sonoyama R, et al
    Factors associated with postoperative oral dysfunction in patients with oral cancer: a structural equation modeling study.
    Oral Oncol. 2025;168:107577.
    

    >> Share

    
    
29. KRISHNAN M, Jothishanmugam A, Mari A, Babu S, et al
    Preserving the mandible, protecting the patient: A commentary on fracture risk following marginal mandibulectomy in head and neck cancer.
    Oral Oncol. 2025;168:107575.
    

    >> Share

    
    
30. ASHOKKUMAR K
    Letter to the editor - a preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus.
    Oral Oncol. 2025;168:107580.
    

    >> Share

    
    
31. YU Z, Zhuang Z, Zhao X, Chi H, et al
    Advancing AI-driven pathology in oral cancer: opportunities for enhanced TIL assessment and clinical integration.
    Oral Oncol. 2025;168:107586.
    

    >> Share

    
    
32. SUDARSON J
    Commentary on "molecular features of T and N stage progression in laryngeal cancer".
    Oral Oncol. 2025;168:107587.
    

    >> Share

    
    
33. DENG J, Murphy BA, Andersen LP, McMenamin E, et al
    Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: a pilot randomized controlled trial.
    Oral Oncol. 2025;168:107556.
    

    >> Share

    
    

    
    PLoS One

34. KURAHASHI Y, Tomita T, Okugawa T, Kitajima K, et al
    Preoperative assessment using a scoring system after neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer: Who can avoid surgery?
    PLoS One. 2025;20:e0328835.
    

    >> Share

    
    
35. DE ROEST RH, Buijze M, Veth M, de Lint K, et al
    An unexpected role of CLASP1 in radiation response and S-phase regulation of head and neck cancer cells.
    PLoS One. 2025;20:e0329731.
    

    >> Share

    
    
36. ZHOU J, Liu S, Deng J, He L, et al
    Premature termination of DNA Damage Repair by 3-Methyladenine potentiates cisplatin cytotoxicity in nasopharyngeal carcinoma cells.
    PLoS One. 2025;20:e0329272.
    

    >> Share

    
    

    
    Radiother Oncol

37. YANG C, Shen M, Long L, Meng Z, et al
    The potential value of IVIM MR for radiation-related hypothyroidism in nasopharyngeal carcinoma.
    Radiother Oncol. 2025;211:111065.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share